Following ‘CRISPR Babies’ Scandal, Senators Call for International Gene Editing Guidelines
By Andrew Joseph,
STAT+
| 07. 15. 2019
A bipartisan trio of senators has introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
A bipartisan trio of senators on Monday introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
The resolution from Sens. Dianne Feinstein (D-Calif.), Marco Rubio (R-Fla.), and Jack Reed (D-R.I.) also reiterated support for international groups working to produce guidelines for the clinical use of germline editing — meaning changes to the DNA in sperm, eggs, or early embryos that would be passed down to future generations.
If passed, the resolution would not change U.S. law; editing embryos with the purpose of creating children is already illegal in the United States. But the action by the senators stands out, since some members of Congress have recently expressed some openness to lifting the ban on editing embryos used to start pregnancies. Scientists in other countries have also announced plans to continue pursuing such experiments, and some scientific and patient advocacy groups have emphasized how germline editing, once the technology improves, could stave off cases of genetic disease.
“Gene editing is a powerful technology that...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...